ARTICLE | Clinical News
Miltefosine regulatory update
July 28, 2008 7:00 AM UTC
EMEA's Committee for Orphan Medical Products (COMP) issued a positive opinion to grant Orphan Drug designation for ExperGen's miltefosine to treat cutaneous T cell lymphoma (CTCL). ...